The Abdominal Aortic Aneurysm
Monday, April 3, 2006 - Wednesday, April 5, 2006
St. Luke's-Roosevelt Hospital
Presented by the New York Academy of Sciences and the Columbia University College of Physicians and Surgeons
An increase in incidence of abdominal aortic aneurysm is predicted as an extension of the advancing age of our population. Novel strategies for treatment and prevention need to be considered. Interdisciplinary approaches to this disease will aid in prevention and treatment. This course will integrate new insights into the etiology and pathology of aneurismal disease, including physiologic and genetic causes.
- M. David Tilson III, MD (Columbia University & St. Luke's-Roosevelt Hospital Center)
- Helena Kuivaniemi, MD, PhD (Wayne State University School of Medicine)
- Gilbert R. Upchurch, Jr., MD (University of Michigan Cardiovascular Center)
We gratefully acknowledge the support of: the National Heart Lung and Blood Institute/NIH, Anonymous, Cook Group Inc., Endologix, Macy Foundation, Medtronic, W. L. Gore and Yamaguchi University
This is a CME-accredited program.
- Assess the benefits of risk of rupture assessment at different ages and thresholds of abdominal aortic aneurysm in the context of epidemiologic studies.
- Examine the use of animal models in the study of abdominal aortic aneurysm and its underlying pathobiology.
- Integrate data on susceptibility and genetic causes of abdominal aortic aneurysms.
- Epidemiology and initiatives to prevent death from rupture.
- Animal models and their relevance to pathophysiology and prevention.
- Enzymology—another approach to interventional pharmacology.
- Biological aspects of endovascular devices to repair abdominal aortic aneurysm.
- Molecular biology and immunology in abdominal aortic aneurysm.